Y Intercept Hong Kong Ltd Purchases 98,932 Shares of UnitedHealth Group Incorporated $UNH

Y Intercept Hong Kong Ltd boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16,191.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 99,543 shares of the healthcare conglomerate’s stock after buying an additional 98,932 shares during the quarter. UnitedHealth Group makes up approximately 0.8% of Y Intercept Hong Kong Ltd’s holdings, making the stock its 2nd largest holding. Y Intercept Hong Kong Ltd’s holdings in UnitedHealth Group were worth $31,054,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Nabity Jensen Investment Management Inc lifted its stake in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after purchasing an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC raised its stake in UnitedHealth Group by 8.9% during the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after buying an additional 25 shares during the period. HHM Wealth Advisors LLC raised its stake in UnitedHealth Group by 0.9% during the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after buying an additional 26 shares during the period. Brogan Financial Inc. raised its stake in UnitedHealth Group by 3.4% during the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after buying an additional 27 shares during the period. Finally, West Wealth Group LLC raised its stake in UnitedHealth Group by 3.2% during the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock worth $462,000 after buying an additional 27 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on the company. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Sanford C. Bernstein lifted their price target on UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Truist Financial lifted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Finally, Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday. Eighteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $385.13.

UnitedHealth Group Trading Up 0.6%

UnitedHealth Group stock opened at $362.78 on Monday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $328.56 billion, a P/E ratio of 15.72, a PEG ratio of 2.34 and a beta of 0.47. The stock has a 50-day simple moving average of $338.43 and a 200 day simple moving average of $335.78.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 EPS. The company’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.